Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBAY | RDY | TEVA | MYL | BHC |
| Company | Cymabay Therapeutics | Dr. Reddy's Laboratories Ltd ADR | Teva Pharmaceutical Industries ADR | Mylan NV Ord Shs | Bausch Health Companies Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NYSE |
| Open | 32.49 | 71.10 | 13.17 | 15.64 | 8.66 |
| High | 32.50 | 71.36 | 13.21 | 16.15 | 8.78 |
| Low | 32.48 | 70.79 | 12.75 | 15.34 | 8.43 |
| Last | 32.48 | 70.91 | 12.78 | 15.86 | 8.60 |
| Change | +0.01 | -0.40 | -0.40 | +0.31 | -0.06 |
| % Change | +0.03% | -0.56% | -3.03% | +1.96% | -0.69% |
| Volume | 8,356,200 | 97,100 | 8,957,300 | 26,574,100 | 2,183,600 |
| 20-Day Average Volume | 3,390,805 | 169,365 | 8,941,595 | 8,612,350 | 4,039,170 |
| Previous Close | 32.47 | 71.31 | 13.18 | 15.55 | 8.66 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 32.35 | 72.75 | 13.80 | 15.15 | 9.54 |
| 20-Day Raw Stochastic | 94.12% | 3.29% | 1.75% | 86.27% | 7.74% |
| 20-Day Relative Strength | 78.00% | 39.66% | 41.08% | 55.75% | 41.41% |
| Weighted Alpha | +247.60 | +15.21 | +56.51 | -23.10 | -1.68 |
| Today's Opinion | 100% Buy | 24% Buy | 56% Buy | 40% Sell | 56% Buy |
| Previous Opinion | 100% Buy | 24% Buy | 56% Buy | 64% Sell | 56% Buy |
| Last Month's Opinion | 100% Buy | 56% Buy | 88% Buy | 64% Sell | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 03/14/24 | -2.44% since 04/11/24 | -7.86% since 04/11/24 | +4.86% since 11/09/20 | -4.12% since 04/11/24 |
| Low | 32.44 on 03/15/24 | 70.79 on 04/18/24 | 12.75 on 04/18/24 | 15.10 on 11/10/20 | 8.43 on 04/18/24 |
| High | 32.50 on 03/21/24 | 72.39 on 04/12/24 | 13.70 on 04/12/24 | 16.15 on 11/16/20 | 8.98 on 04/15/24 |
| 1-Month | |||||
| %Chg | +0.90% since 02/21/24 | -6.07% since 03/18/24 | -4.05% since 03/18/24 | +0.92% since 10/16/20 | -8.32% since 03/18/24 |
| Low | 32.15 on 02/22/24 | 70.79 on 04/18/24 | 12.75 on 04/18/24 | 14.00 on 10/29/20 | 8.36 on 04/11/24 |
| High | 32.50 on 03/21/24 | 74.44 on 04/01/24 | 14.47 on 04/08/24 | 16.15 on 11/16/20 | 11.46 on 04/03/24 |
| 3-Month | |||||
| %Chg | +46.17% since 12/21/23 | +4.05% since 01/18/24 | +16.29% since 01/18/24 | -2.07% since 08/14/20 | +4.12% since 01/18/24 |
| Low | 22.11 on 01/26/24 | 67.35 on 01/22/24 | 10.86 on 01/19/24 | 14.00 on 10/29/20 | 7.68 on 02/05/24 |
| High | 32.50 on 03/21/24 | 77.72 on 02/23/24 | 14.47 on 04/08/24 | 17.03 on 08/19/20 | 11.46 on 04/03/24 |
| 6-Month | |||||
| %Chg | +122.47% since 09/21/23 | +4.66% since 10/18/23 | +51.06% since 10/18/23 | +4.58% since 05/15/20 | +10.82% since 10/18/23 |
| Low | 12.32 on 10/13/23 | 63.72 on 11/03/23 | 8.06 on 10/23/23 | 14.00 on 10/29/20 | 6.53 on 11/13/23 |
| High | 32.50 on 03/21/24 | 77.72 on 02/23/24 | 14.47 on 04/08/24 | 19.24 on 06/08/20 | 11.46 on 04/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,726,235 | 11,833,320 | 14,327,581 | 8,586,212 | 3,142,543 |
| Shares Outstanding, K | 114,724 | 166,878 | 1,121,094 | 541,546 | 365,412 |
| Annual Sales | 31,070,000 | 2,992,000,000 | 15,846,000,000 | 11,500,500,000 | 8,757,000,000 |
| Annual Net Income | -105,370,000 | 548,000,000 | -559,000,000 | 16,800,000 | -592,000,000 |
| Last Quarter Sales | 60,000 | 865,780,000 | 4,457,000,000 | 2,972,100,000 | 2,408,000,000 |
| Last Quarter Net Income | -41,900,000 | 165,470,000 | 429,000,000 | 185,700,000 | -39,000,000 |
| 60-Month Beta | 0.32 | 0.58 | 1.05 | 1.45 | 0.85 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 02/28/24 | 0.99 on 01/31/24 | 1.00 on 01/31/24 | 0.36 on 11/06/20 | 1.15 on 02/22/24 |
| Latest Earnings Date | 03/21/24 | 05/08/24 | 05/08/24 | 11/06/20 | 05/02/24 |
| Most Recent Dividend | N/A | 0.410 on 07/28/23 | 0.072 on 11/27/17 | 0.060 on 06/27/07 | 1.000 on 11/10/10 |
| Next Ex-Dividends Date | N/A | 07/28/23 | 11/27/17 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.82 | 5.34 | 3.29 | 2.47 |